Intra-Cellular Therapies Inc. is a biopharmaceutical company that innovates in the development of novel drugs for treating complex psychiatric and neurological disorders. Its primary focus is on treat... Intra-Cellular Therapies Inc. is a biopharmaceutical company that innovates in the development of novel drugs for treating complex psychiatric and neurological disorders. Its primary focus is on treatments that address underlying dysfunctions in neuronal signaling, aiming to improve the quality of life for patients suffering from these conditions. The company is a significant player in the healthcare sector, particularly impacting the psychiatric and neurological segments. Through research and development, it creates therapies that target specific mechanisms within brain cells, offering potential breakthroughs in understanding and treating mental health issues. With a commitment to transforming patient care, Intra-Cellular Therapies Inc. contributes to the pharmaceutical landscape by providing new and effective treatment options. Its work not only addresses clinical needs but also has the potential to drive advancements in medical science, thereby holding a vital role in the intersection of medical research and practical healthcare solutions.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Group Entities data not yet covered for Intra-Cellular Therapies

We have not yet reviewed Intra-Cellular Therapies's disclosures for Group Entities data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review Intra-Cellular Therapies's data?

Create a free Tracenable account to signal interest in having our team review data for Intra-Cellular Therapies.

Legal Center Contact Us